Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.
A study looking at magnetic resonance imaging (MRI) scans to assess Hodgkin lymphoma in children and young people - MELT
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
A study looking at using a new type of MRI scan to assess Hodgkin lymphoma and its response to treatment in children and young people.
The study is for children and young people up to and including the age of 20. We use the term 'you' in this summary, but if you are a parent, we are referring to your child.
Doctors will often use a CT scan, PET scan, MRI scan and ultrasound scan to find out where the Hodgkin lymphoma is. They will also use these scans to find out how well it has responded after treatment. The researchers want to compare the new type of MRI scan to these scans.
The aim of this study is to find out how good the new type of MRI scan is at assessing Hodgkin lymphoma and its response to treatment.
Who can enter
You may be able to enter this trial if you
- Have Hodgkin lymphoma
- Are taking part in the Euronet PHL-C1 trial or LP1 trial OR are to have chemotherapy according to the Euronet trials – your doctor can advise about this
- Are 5 to 20 years old
You cannot enter this trial if you
- Are not able to have an MRI scan - if you have certain types of metal surgical clips or plates in your body, or a pacemaker for example
- Have had cancer before unless there has been no sign of your disease in the past 5 years
- Have had chemotherapy or radiotherapy in the past 2 years
- Are pregnant or breastfeeding
This study will recruit 55 children and young people who attend the University College London Hospital.
You will have the new type of MRI scan as well as the standard scans before and after your treatment. The researchers will then compare these MRI scans with your standard scans to see which is better.
There are no extra hospital visits if you take part in this trial. But the new type of MRI scan will take about 1 hour to do each time.
You may have a reaction to the injection for the scan. This could include sweating, rash and difficulty breathing.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Stuart Taylor
Cancer Research UK
NIHR Clinical Research Network: Cancer
University College London (UCL)